Moderna shares fall after company cuts 2021 forecast for Covid vaccine sales

Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.

Boston Globe | Getty Images

Moderna shares fell 8% on Thursday after it cut its Covid-19 vaccine sales forecast for the year to between $15 billion and $18 billion from $20 billion.

This is a developing story. Please check back for updates.

Moderna shares fall after company cuts 2021 forecast for Covid vaccine sales

Tough times for income investors: Even with payouts at a record, dividend yields are measly

Ford to repurchase up to $5 billion in junk bonds as it restructures its balance sheet

Dow Jones Rises 175 Points After Jobless Claims, GDP Data; Schwab Drops On Downgrade

Warren Buffett and Morgan Stanley Have One Thing in Common: They Both Like These 2 Stocks

Ask an Advisor: ‘How Can I Mitigate This Situation?’ My Tax Bill Is Huge Because My Investment Accounts Don’t Withhold Capital Gains

Constellation Brands taps food-and-travel streamer Tastemade to help draw new customers

Comments

Leave a reply Cancel reply

More in Market News

Senate Democrats press federal bank regulators to implement stronger capital requirements

OpenAI faces complaint to FTC that seeks investigation and suspension of ChatGPT releases

Apple analyst Kuo says mixed-reality headset faces delay of 1 to 2 months, WWDC launch uncertain

Fear gauge shows Wall Street’s worries about a banking crisis have largely subsided

Get the daily email with market news.

Top News